Extracted text (via pymupdf)
32634 characters
Department of Health and Human Services
Health Resources and Services Administration
Notice of Award
FAIN# UT833944
Federal Award Date: 01/10/2025
Recipient Information
1. Recipient Name
MARICOPA, COUNTY OF
301 W Jefferson St
Phoenix, AZ 85003‐2143
2. Congressional District of Recipient
03
3. Payment System Identifier (ID)
1866000472B9
4. Employer Identification Number (EIN)
866000472
5. Data Universal Numbering System (DUNS)
602062515
6. Recipient's Unique Entity Identifier
LM85MG1513K5
7. Project Director or Principal Investigator
Jeremy K Hyvarinen
Ryan White Subdivision Manager
Jeremy.Hyvarinen@maricopa.gov
(602)571‐7267
8. Authorized Official
Jeremy K Hyvarinen
Ryan White Subdivision Manager
jeremy.hyvarinen@maricopa.gov
(602)647‐2996
Federal Agency Information
9. Awarding Agency Contact Information
Beverly H Smith
Grants Management Specialist
Office of Federal Assistance Management (OFAM)
Division of Grants Management Office (DGMO)
Bsmith@HRSA.GOV
(301) 443‐7065
10. Program Official Contact Information
Chau D Nguyen
Project Officer
HIV/AIDS Bureau (HAB)
cnguyen1@hrsa.gov
(301) 443‐5785
Federal Award Information
11. Award Number
2 UT8HA33944‐06‐00
12. Unique Federal Award Identification Number (FAIN)
UT833944
13. Statutory Authority
42 U.S.C. § 243(c); 300ff‐11 et seq.
14. Federal Award Project Title
Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B
15. Assistance Listing Number
93.686
16. Assistance Listing Program Title
Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B
17. Award Action Type
Competing Continuation
18. Is the Award R&D?
No
Summary Federal Award Financial Information
19. Budget Period Start Date 03/01/2025 ‐ End Date 02/28/2026
20. Total Amount of Federal Funds Obligated by this Action
$1,076,917.00
20a. Direct Cost Amount
20b. Indirect Cost Amount
$0.00
21. Authorized Carryover
$0.00
22. Offset
$0.00
23. Total Amount of Federal Funds Obligated this budget period
$1,076,917.00
24. Total Approved Cost Sharing or Matching, where applicable
$0.00
25. Total Federal and Non‐Federal Approved this Budget Period
$1,076,917.00
26. Project Period Start Date 03/01/2025 ‐ End Date 02/28/2030
27. Total Amount of the Federal Award including Approved
Cost Sharing or Matching this Project Period
$1,076,917.00
28. Authorized Treatment of Program Income
Addition
29. Grants Management Officer – Signature
Karen Mayo on 01/10/2025
30. Remarks
Page 1
A printer version document only. The document may contain some accessibility challenges for the screen reader users. To access same information, a fully 508 compliant accessible HTML version is available on the HRSA Electronic Handbooks. If you need more
information, please contact HRSA contact center at 877-464-4772, 8 am to 8 pm ET, weekdays.
HIV/AIDS Bureau (HAB)
Notice of Award
Award Number: 2 UT8HA33944‐06‐00
Federal Award Date: 01/10/2025
31. APPROVED BUDGET: (Excludes Direct Assistance)
[X] Grant Funds Only
[ ]
Total project costs including grant funds and all other financial participation
a.
Salaries and Wages:
$0.00
b.
Fringe Benefits:
$0.00
c.
Total Personnel Costs:
$0.00
d.
Consultant Costs:
$0.00
e.
Equipment:
$0.00
f.
Supplies:
$0.00
g.
Travel:
$0.00
h.
Construction/Alteration and Renovation:
$0.00
i.
Other:
$1,076,917.00
j.
Consortium/Contractual Costs:
$0.00
k.
Trainee Related Expenses:
$0.00
l.
Trainee Stipends:
$0.00
m. Trainee Tuition and Fees:
$0.00
n.
Trainee Travel:
$0.00
o.
TOTAL DIRECT COSTS:
$1,076,917.00
p.
INDIRECT COSTS (Rate: % of S&W/TADC):
$0.00
i. Indirect Cost Federal Share:
$0.00
ii. Indirect Cost Non-Federal Share:
$0.00
q.
TOTAL APPROVED BUDGET:
$1,076,917.00
i. Less Non‐Federal Share:
$0.00
ii. Federal Share:
$1,076,917.00
32. AWARD COMPUTATION FOR FINANCIAL ASSISTANCE:
a. Authorized Financial Assistance This Period
$1,076,917.00
b. Less Unobligated Balance from Prior Budget Periods
i. Additional Authority
$0.00
ii. Offset
$0.00
c. Unawarded Balance of Current Year's Funds
$0.00
d. Less Cumulative Prior Award(s) This Budget Period
$0.00
e. AMOUNT OF FINANCIAL ASSISTANCE THIS ACTION
$1,076,917.00
33. RECOMMENDED FUTURE SUPPORT:
(Subject to the availability of funds and satisfactory progress of project)
YEAR
TOTAL COSTS
07
$1,076,917.00
08
$1,076,917.00
09
$1,076,917.00
10
$1,076,917.00
34. APPROVED DIRECT ASSISTANCE BUDGET: (In lieu of cash)
a. Amount of Direct Assistance
$0.00
b. Less Unawarded Balance of Current Year's Funds
$0.00
c. Less Cumulative Prior Award(s) This Budget Period
$0.00
d. AMOUNT OF DIRECT ASSISTANCE THIS ACTION
$0.00
35. FORMER GRANT NUMBER
36. OBJECT CLASS
41.15
37. BHCMIS#
38. THIS AWARD IS BASED ON THE APPLICATION APPROVED BY HRSA FOR THE PROJECT NAMED IN ITEM 14. FEDERAL AWARD PROJECT TITLE AND IS SUBJECT TO THE
TERMS AND CONDITIONS INCORPORATED EITHER DIRECTLY OR BY REFERENCE AS:
a. The program authorizing statue and program regulation cited in this Notice of Award; b. Conditions on activities and expenditures of funds in certain other applicable
statutory requirements, such as those included in appropriations restrictions applicable to HRSA funds; c. 45 CFR Part 75; d. National Policy Requirements and all other
requirements described in the HHS Grants Policy Statement; e. Federal Award Performance Goals; and f. The Terms and Conditions cited in this Notice of Award. In the event
there are conflicting or otherwise inconsistent policies applicable to the award, the above order of precedence shall prevail. Recipients indicate acceptance of the award, and
terms and conditions by obtaining funds from the payment system.
39. ACCOUNTING CLASSIFICATION CODES
FY‐CAN
CFDA
DOCUMENT
NUMBER
AMT. FIN. ASST.
AMT. DIR. ASST.
SUB PROGRAM CODE
SUB ACCOUNT CODE
25 - 377ABGR
93.914
25UT8HA33944
$1,076,917.00
$0.00
N/A
25UT8HA33944
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/10/2025 10:21:34 AM
Award Number: 2 UT8HA33944-06-00
Page 2
HRSA Electronic Handbooks (EHBs) Registration Requirements
The Project Director of the grant (listed on this NoA) and the Authorizing Official of the grantee organization are required to register (if not already
registered) within HRSA's Electronic Handbooks (EHBs). Registration within HRSA EHBs is required only once for each user for each
organization they represent. To complete the registration quickly and efficiently we recommend that you note the 10-digit grant number from box
4b of this NoA. After you have completed the initial registration steps (i.e.,created an individual account and associated it with the correct grantee
organization record), be sure to add this grant to your portfolio. This registration in HRSA EHBs is required for submission of noncompeting
continuation applications. In addition, you can also use HRSA EHBs to perform other activities such as updating addresses, updating email
addresses and submitting certain deliverables electronically. Visit
https://grants3.hrsa.gov/2010/WebEPSExternal/Interface/common/accesscontrol/login.aspx to use the system. Additional help is available online
and/or from the HRSA Call Center at 877-Go4-HRSA/877-464-4772.
Terms and Conditions
Failure to comply with the remarks, terms, conditions, or reporting requirements may result in a draw down restriction being placed
on your Payment Management System account or denial of future funding.
Grant Specific Term(s)
1.
This action reflects a new document number. Please refer to this number when contacting the Payment Management System or submitting
drawdown requests.
2.
All post-award requests, such as significant budget revisions or a change in scope, must be submitted as a Prior Approval action via the
Electronic Handbooks (EHBs) and approved by HRSA prior to implementation. Grantees under “Expanded Authority,” as noted in the
Remarks section of the Notice of Award, have different prior approval requirements. See “Prior-Approval Requirements” in the DHHS Grants
Policy Statement:https://www.hhs.gov/sites/default/files/hhs-grants-policy-statement-october-2024.pdf.
3.
The funds for this award are in a sub-account in the Payment Management System (PMS). This type of account allows recipients to
specifically identify the individual grant for which they are drawing funds and will assist HRSA in monitoring the award. Access to the PMS
account number is provided to individuals at the organization who have permissions established within PMS. The PMS sub-account code
can be found on the HRSA specific section of the NoA (Accounting Classification Codes). Both the PMS account number and sub-account
code are needed when requesting grant funds. Please note that for new and competing continuation awards issued after 10/1/2020,
the sub-account code will be the document number.
You may use your existing PMS username and password to check your organizations’ account access. If you do not have access, complete a
PMS Access Form (PMS/FFR Form) found at: https://pmsapp.psc.gov/pms/app/userrequest. If you have any questions about accessing
PMS, contact the PMS Liaison Accountant as identified at:
http://pms.psc.gov/find-pms-liaison-accountant.html
4.
45 CFR Part 75 applies to all federal funds associated with the award. Part 75 has been effective since December 26, 2014. All references
to prior OMB Circulars for the administrative and audit requirements and the cost principles that govern Federal monies associated with this
award are superseded by the Uniform Guidance 2 CFR Part 200 as codified by HHS at 45 CFR Part 75.
5.
HRSA is operating under a Continuing Resolution; therefore, this award provides partial funding based on the continuation of FY 2024
program requirements, funding levels, and specialized reporting requirements. Additions and revisions to these Terms and Conditions may
be necessary once HRSA receives a final FY 2025 appropriations. A revised Notice of Award (NoA) will be issued to reflect any changes to
funding amounts, Terms and Conditions, and/or reporting requirements.
6.
As a condition of accepting this award the recipient must comply with data requirements of the RSR and will mandate compliance by each of
your subrecipients. The RSR captures information necessary to demonstrate program performance and accountability. All EHE core service
and support service providers are required to submit client-level data as instructed in the RSR manual. Please refer to the RSR Webpage for
additional information.
7.
Recipients may request carryover of any unobligated balance (UOB) from the Ending the HIV Epidemic in the U.S. initiative funding
throughout the life of the period of performance ending on February 28, 2030. A Prior Approval request for carryover of UOB must be
submitted via HRSA’s Electronic Handbooks (EHBs). Funds may not be used without written approval from the Division of Grants
Management Operations (DGMO). When submitting your Prior Approval request, you must include the year you are requesting the funds to
be carried from and the amount. It is your responsibility to track the UOB based on the project budget period during the five year period of
performance.
Program Specific Term(s)
1.
In accordance with 45 CFR § 75.322(b), the recipient may copyright any work that is subject to copyright and was developed, or for which
ownership was purchased, under an award. HRSA HAB reserves a royalty-free, nonexclusive and irrevocable right to reproduce, publish, or
otherwise use the work for Federal purposes, and to authorize others to do so.
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/10/2025 10:21:34 AM
Award Number: 2 UT8HA33944-06-00
Page 3
2.
Funding beyond this budget period is contingent upon the availability of appropriated funds for this program in subsequent fiscal years,
recipient satisfactory performance, and a decision that continued funding is in the best interest of the Federal Government.
3.
Unless otherwise specified, all Conditions and Reporting Requirements must be electronically submitted through the HRSA Electronic
Handbooks (EHBs).
4.
As required by the Federal Funding Accountability and Transparency Act of 2006 (Pub. L. 109–282), as amended by section 6202 of Public
Law 110–252, recipients must report information for each subaward of $30,000 or more in Federal funds and executive total compensation
as outlined in Appendix A to 2 CFR Part 170 (http://www.hrsa.gov/grants/ffata.html). The FFATA reporting requirements apply for the duration
of the project period and so include all subsequent award actions to aforementioned HRSA grants and cooperative agreement awards (e.g.,
Type 2 (competing continuation), Type 5 (non-competing continuation), etc.). Subawards to individuals are exempt from these requirements.
For more information, visit: http://www.hrsa.gov/grants/ffata.html.
5.
RWHAP funds may not be used to make cash payments to intended clients of RWHAP-funded services. This prohibition includes cash
incentives and cash intended as payment for RWHAP services. Where direct provision of the service is not possible or effective, store gift
cards, vouchers, coupons, or tickets that can be exchanged for a specific service or commodity (e.g., food or transportation) must be used.
Store gift cards that can be redeemed at one merchant or an affiliated group of merchants for specific goods or services that further the
goals and objectives of the RWHAP are also allowable as incentives for eligible program participants. Recipients are advised to administer
voucher and store gift card programs in a manner which assures that they cannot be exchanged for cash or used for anything other than the
allowable goods or services, and that systems are in place to account for disbursed vouchers and store gift cards. Note: General-use
prepaid cards are considered “cash equivalent” and are therefore unallowable. Such cards generally bear the logo of a payment network,
such as Visa, MasterCard, or American Express, and are accepted by any merchant that accepts those credit or debit cards as payment.
Gift cards that are cobranded with the logo of a payment network and the logo of a merchant or affiliated group of merchants are general-use
prepaid cards, not store gift cards, and therefore are also unallowable.
6.
The recipient shall make all files, including captioning, audio descriptions, videos, tables, graphics/pictures, registration forms, presentations
(both audio and video) or other types of proprietary format files – e.g., Adobe Portable Document Format (.pdf), Microsoft Office PowerPoint
(.ppt) and Microsoft Excel (.xls), fully accessible to members of the public with disabilities. Technical and functional standards for accessibility
are codified at 36 CFR Part 1194 and may be accessed through the Access Board’s Web site at http://www.access-board.gov.
7.
Funding will be provided in the form of cooperative agreement. A cooperative agreement, as opposed to a grant, is an award instrument of
financial assistance where substantial involvement is anticipated between HRSA and the recipient during performance of the contemplated
project. The recipient is expected to collaborate with HAB and its RWHAP recipients to achieve the expectations described in the program
expectations section. Certain activities must be planned jointly and include HAB's input. HRSA HAB must be aware of all project activities in
sufficient time to provide input and/or assistance. This substantial involvement is in addition to the usual monitoring and technical assistance
provided under the cooperative agreement.
As a cooperative agreement, HRSA programmatic involvement will include:
Providing the expertise of HRSA HAB personnel and other relevant resources to support the efforts of the initiative activities;
Facilitating partnership and communication with other federal agencies, particularly CDC, to improve coordination efforts;
Facilitating collaboration with the TAP and SCP to assist in the development, implementation, coordination, and integration of initiative
activities;
Participating in the design and direction of the strategies, interventions, tools, and processes to be established and implemented for
accomplishing the goals of the cooperative agreement;
Approving uses of funds outside of existing allowable RWHAP costs and service categories;
Providing ongoing review of the establishment and implementation of activities and measures for accomplishing the goals of the
cooperative agreement;
Participating, as appropriate, in conference calls and meetings that are conducted during the project period of the cooperative
agreement;
Reviewing and concurring with all information products prior to dissemination; and
Facilitating the dissemination of project findings, best practices, evaluation data, and other information developed as part of this
project to the broader network of RWHAP recipients.
In collaboration with HRSA, the cooperative agreement recipient’s responsibilities will include:
Completing proposed initiative work plan activities within the five-year project period;
Collaborating with HRSA on review of activities, procedures, and budget items, including timely communication with project officer;
Developing and implementing a methodology, including proposed metrics, to measure the impact of proposed activities, as well as
reporting on outcomes;
Ensuring proposed activities are based on documented need, targeted for maximum impact on HIV care continuum outcomes, and
designed to reach the identified target population(s);
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/10/2025 10:21:34 AM
Award Number: 2 UT8HA33944-06-00
Page 4
Coordinating the initiative activities with their existing RWHAP programs;
Collaborating with CDC funded organizations, health centers, and other local and state government agencies on implementing
initiative activities;
Collaborating with the TAP and SCP on the development, implementation, coordination, and integration of initiative activities;
Developing a sustainability plan to support successful activities following conclusion of the cooperative agreement;
Modifying activities as necessary to ensure relevant outcomes for the project; and
Participating in the dissemination of project findings, best practices, and lessons learned, including adherence to HRSA guidelines
pertaining to acknowledgment and disclaimer on all products produced by HRSA award funds
8. As a condition of accepting this award the recipient must adhere to all program policies and guidance governing the EHE program
9.
If applicable, recipients must submit the Tangible Personal Property Report (TPPR) (SF-428) and any related forms. The report must be
submitted within 90 days after the project period ends. Recipients are required to report all equipment with an acquisition cost of $10,000 or
more per unit acquired by the recipient with award funds. TPPRs must be submitted electronically through HRSA EHBs.
10.
Recipients are required to track and report all program income on the annual Federal Financial Report. All program income earned must
be used to further the objectives of the Ryan White HIV/AIDS Program. For additional information, see PCN #15-03 available online at
https://hab.hrsa.gov/program-grants-management/policy-notices-and-program-letters.
11.
Recipients must submit an annual Non-Competing Continuation (NCC) Progress Report via the HRSA EHBs 90 days prior to the budget
period end date. Submission and HRSA approval of this NCC Progress Report triggers the budget period renewal and release of
subsequent year funds. The report demonstrates recipient progress on program-specific goals and collects core performance
measurement data to measure the progress and impact of the project.
12.
For all action steps that require input from the HAB Project Officer and other HAB staff, you must allow for at least a three (3) week
response time for information, approval, planning, or technical assistance. Work plan tables must be adjusted to include the minimum
response time for all relevant activities.
13.
The Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, 45 CFR § 75.352, requires
recipients to monitor the activities of subrecipients to ensure funding is used only for authorized purposes, in compliance with federal
statutes, regulations, and the terms and conditions of the subaward, as well as to ensure that performance goals are achieved. Recipients
must ensure that drug rebates and program income earned as a result of the RWHAP award are used only for allowable activities and only
for purposes of the RWHAP award. See section 2616(g) of the Public Health Service Act and 45 CFR 75.307(e)(2). Therefore, recipients
must monitor awards funded through drug rebates and/or program income.
14.
Resumes/CV for key personnel supported by this cooperative agreement and not named in the FY 2025 application must be submitted to
the HRSA Grants Management Office through the EHB Prior Approval Portal for review prior to appointment to the project. This
requirement also includes all key personnel hired due to vacancy, resignation, termination or attrition subsequent to the issue date on the
Notice of Award.
15. This award is subject to 45 CFR part 75--Uniform Administrative Requirements, Cost Principles, and Audit Requirement for HHS Awards.
16.
During each budget period, recipients must include in their program budget travel support for key recipient staff members (one staff
member must be the program director or a designated representative) to attend meetings/conferences identified by HRSA HAB as
essential to EHE administration and implementation. HRSA HAB meetings may include, but are not limited to, the biennial National Ryan
White Conference on HIV Care and Treatment, grant-specific Administrative Reverse Site Visits (ARSV), or targeted technical assistance
events. Meetings may be up to 4 days and are generally held in the Washington, D.C. metropolitan area. If no essential meetings are held
during the budget period, recipients can reallocate funds for other allowable grant expenses. Recipients must comply with 45 CFR Part
75.474 and all other applicable HHS and Federal policies governing travel supported under Federal assistance awards.
17.
This action reflects a new document number. Please refer to this number when contacting the Payment Management System or submitting
drawdown requests. Reporting on the Federal Financial Report (FFR) SF-425 Federal Cash Transaction Report (FCTR) should reflect this
number for all disbursements related to this project period.
18.
Funds may not be used for payments for any item or service to the extent that payment has been made, or reasonably can be expected to
be made, with respect to that item or service under any state compensation program, insurance policy, federal or state health benefits
program or by an entity that provides health services on a prepaid basis (except for a program administered by or providing the services of
the Indian Health Services).
In addition, funds may not be used for the following purposes:
Cash payment to intended recipients of services.
Clinical research.
International travel.
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/10/2025 10:21:34 AM
Award Number: 2 UT8HA33944-06-00
Page 5
Construction (minor alterations and renovations to an existing facility to make it more suitable for the purposes of the award
program are allowable with prior HRSA approval).
Syringe Services Programs (SSPs). Some aspects of SSPs are allowable with HRSA’s prior approval and in compliance with
HHS and HRSA policy.
Pre Exposure Prophylaxis (PrEP) medications and related medical services or Post-Exposure Prophylaxis (PEP), as the
person using PrEP or PEP does not have HIV and therefore not eligible for HRSA HAB initiative funded medication.
19.
The recipient is required to establish and maintain a process for protecting client confidentiality throughout the project period. Client
confidentiality requirements apply to all phases of the project.
20.
As outlined in Notice of Funding Opportunity HRSA-25-063, the only requirement for determining eligibility for EHE service provision is that
the individual has a documented HIV diagnosis. HRSA expects that all new clients who are provided any services (whether EHE or
RWHAP) in an EHE-funded jurisdiction will be counted as an EHE client.
21.
Funds may not be used by grantees or subcontractors for the purchase of vehicles without written approval from the Division of Grants
Management Operations (DGMO).
22.
Consistent with Departmental guidance, HRSA recipients that purchase, are reimbursed or provide reimbursement to other entities for
outpatient prescription drugs are expected to secure the best prices available for such products and to maximize results for the recipient
organization and its patients. Eligible health care organizations/covered entities that enroll in the 340B Program must comply with all 340B
Program requirements and will be subject to audit regarding 340B Program compliance. 340B Program requirements, including eligibility,
can be found at www.hrsa.gov/opa.
23.
If the recipient expends any of the Initiative award on the AIDS Drug Assistance Program (ADAP), it must comply with data reporting
requirements of the ADAP Data Report (ADR) for those funds. Acceptance of this award indicates that you will comply with data
requirements of the ADR and will mandate compliance by each of your contractors and subcontractors. The ADR captures information
necessary to demonstrate program performance and accountability. Please refer to the ADR Webpage for more information.
24.
Submit, every two (2) years, to the lead State or MTA agency for the EHE initiative, audits consistent with 45 CFR 75 Subpart F, regarding
funds expended in accordance with this title.
25.
The EHE initiative specifies criteria for the expenditure of program funds as follows:
Recipient costs for grant administration may not exceed ten (10) percent of the grant award. Planning and evaluation costs may not
exceed ten (10) percent of the grant award. Collectively, recipient administration and planning and evaluation costs may not exceed
fifteen (15) percent of the grant award. The aggregate total of administrative expenditures for subrecipients, including all indirect
costs, may not exceed 10 percent of the aggregate amount of all subawards.
If the recipient elects to expend funds for clinical quality management activities that amount shall not exceed the lesser of 5 percent of
the total grant funds or $3 million.
26.
Any recipients that collect rebates on ADAP medication purchases funded through EHE must adhere to outlined provisions in HRSA HAB
PCN # 15-04: Utilization and Reporting of Pharmaceutical Rebates. See https://hab.hrsa.gov/sites/default/files/hab/Global/pcn_15-
04_pharmaceutical_rebates.pdf
27.
Funds awarded for pharmaceuticals must only be spent to assist clients who have been determined not eligible for other pharmaceutical
programs, especially the AIDS Drug Assistance Program and/or for drugs that are not on the State ADAP or Medicaid formulary.
28.
All recipients who are providing services under EHE that are available in the Medicaid State plan must have entered into a participation
agreement under the State plan and be qualified to receive payments under such plan, or receive a waiver from this requirement.
Standard Term(s)
1.
Your organization must have policies, procedures, and financial controls to follow all the General Terms and Conditions. HRSA awards are
based on the application submitted and approved by HRSA. All awards are subject to the General Terms and Conditions, in addition to
those included in the Notice of Award or referenced in documents and attachments.
Reporting Requirement(s)
1.
Due Date: Annually (Budget Period) Beginning: Budget Start Date Ending: Budget End Date, due 90 days after end of reporting
period.
The recipient must submit, within 90 days after budget period end date, an annual Federal Financial Report (FFR). The report should reflect
cumulative reporting within the project period of the document number. All FFRs must be submitted through the Payment Management
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/10/2025 10:21:34 AM
Award Number: 2 UT8HA33944-06-00
Page 6
System (PMS). Technical questions regarding the FFR, including system access should be directed to the PMS Help Desk by submitting a
ticket through the self-service web portal (PMS Self-Service Web Portal), or calling 877-614-5533.
2.
Due Date: 09/30/2025
Biannual Progress Report: Recipients must submit two progress reports during the budget period via the HRSA Electronic Handbooks
(EHB) system. The information will include recipient progress on program specific goals and strategies; key accomplishments including a
list of all developed materials, tools and websites; barriers encountered and how resolved; and responses to summary questions regarding
overall impact. Recipients must submit the report on-line in the EHBs. The format for these reports will be provided by the program staff
within the EHB.
3.
Due Date: 03/31/2026
Biannual Progress Report: Recipients must submit two progress reports during the budget period via the HRSA Electronic Handbooks
(EHB) system. The information will include recipient progress on program specific goals and strategies; key accomplishments including a
list of all developed materials, tools and websites; barriers encountered and how resolved; and responses to summary questions regarding
overall impact. Recipients must submit the report on-line in the EHBs. The format for these reports will be provided by the program staff
within the EHB.
4. Due Date: Within 90 Days of Project End Date
The recipient must submit an annual Initiative Expenditure Report.
5.
Due Date: 03/30/2026
Submit the Ryan White Services Report (RSR) which consists of recipient, service provider, and client level reports for the calendar year via
the EHBs by 6:00 PM ET on the last Monday in March. See http://hab.hrsa.gov/manageyourgrant/reportingrequirements.html for additional
information
6.
Due Date: 06/15/2025
As a condition of accepting this award the recipient must comply with data requirements of the Ending the HIV Epidemic Aggregate Module
and will mandate compliance by each of your subrecipients. EHE funded subrecipients must submit a report of aggregate data on a triannual
basis. Subrecipients will report using a standard template that captures aggregate counts of services received by clients during the triannual
period. Further information on additional data needed for this report will be available in the NOA.
7.
Due Date: 10/15/2025
As a condition of accepting this award the recipient must comply with data requirements of the Ending the HIV Epidemic Aggregate Module
and will mandate compliance by each of your subrecipients. EHE funded subrecipients must submit a report of aggregate data on a triannual
basis. Subrecipients will report using a standard template that captures aggregate counts of services received by clients during the triannual
period. Further information on additional data needed for this report will be available in the NOA.
8.
Due Date: 02/15/2026
As a condition of accepting this award the recipient must comply with data requirements of the Ending the HIV Epidemic Aggregate Module
and will mandate compliance by each of your subrecipients. EHE funded subrecipients must submit a report of aggregate data on a triannual
basis. Subrecipients will report using a standard template that captures aggregate counts of services received by clients during the triannual
period. Further information on additional data needed for this report will be available in the NOA.
Failure to comply with these reporting requirements will result in deferral or additional restrictions of future funding decisions.
Contacts
NoA Email Address(es):
Name
Role
Email
Jeremy K Hyvarinen
Program Director, Authorizing Official
jeremy.hyvarinen@maricopa.gov
Note: NoA emailed to these address(es)
All submissions in response to conditions and reporting requirements (with the exception of the FFR) must be submitted via EHBs. Submissions
for Federal Financial Reports (FFR) must be completed in the Payment Management System (https://pms.psc.gov/).
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/10/2025 10:21:34 AM
Award Number: 2 UT8HA33944-06-00
Page 7